The Chicago Entrepreneur

Prescription fills for weight loss drugs Zepbound and Wegovy more than doubled in 2024, GoodRx says

The jump in prescription fills comes despite limited insurance coverage and high out-of-pocket costs for Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound.

Previous post Southwest, American raise sales outlooks, shares jump
Next post MLS Commissioner Don Garber talks Apple subscribers, Messi and growth of soccer